MKI67 and breast carcinoma: Various methods by which proliferation activity in breast cancer is measured, showed conflicting results [27], and the controversies, might be related to the various phase-specificities of the proliferation markers: for example, while Ki-67 is present in all cell-cycle phases except G0, cyclin D and E show their activities only in the G1/S transition [6].